Literature DB >> 11293821

Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques.

N Papaioannou1, P C Tooten, A M van Ederen, J R Bohl, J Rofina, T Tsangaris, E Gruys.   

Abstract

In the aging dog brain lesions develop spontaneously. They share some morphological characteristics with those of Alzheimer 's disease in man. Diffuse and primitive plaques are well known, whereas neuritic plaques rarely develop. Neurofibrillary tangles have not been seen in the canine. The aim of the present investigation was to study major age-related changes of the dog's brain using paraffin sections with respect to cross-immunoreactivity of tau, A beta protein and other immunoreactive components including hydroxynonenal protein, which is a marker for oxidative damage. The occurrence of neurofibrillary tangles and of the protein tau therein was studied in serial brain sections of two dogs with the Gallyas stain and by immunohistochemistry with three different antibodies against tau. Senile plaques were stained with a monoclonal anti-A beta (residues 8-17), polyclonal anti-apolipoprotein E and a monoclonal antibody against 4-hydroxynonenal (HNE). Amyloid deposits and controls were screened by Congo red staining viewed in fluorescent light, followed by polarized light for green birefringence. With the Gallyas stain and one of the antisera against tau, neurofibrillary tangles were revealed in a similar dispersed pattern, whereas the other antitau antisera gave negative results. With the anti-HNE a positive reaction was found in cerebral amyloid deposits and in vascular wall areas where amyloid deposition was confirmed by Congo-red staining, and in perivascular cells and in some neurons. These results indicate that the canine with his tangles and plaques which show oxidative changes, forms a spontaneous modelfor understanding the early changes and their interrelationships in Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11293821     DOI: 10.3109/13506120108993810

Source DB:  PubMed          Journal:  Amyloid        ISSN: 1350-6129            Impact factor:   7.141


  35 in total

1.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.

Authors:  Roy G Cutler; Jeremiah Kelly; Kristin Storie; Ward A Pedersen; Anita Tammara; Kimmo Hatanpaa; Juan C Troncoso; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-15       Impact factor: 11.205

Review 2.  Amyloid-modifying therapies for Alzheimer's disease: therapeutic progress and its implications.

Authors:  Meaghan C Creed; Norton W Milgram
Journal:  Age (Dordr)       Date:  2010-04-20

Review 3.  Antioxidants in the canine model of human aging.

Authors:  Amy L S Dowling; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2011-10-08

Review 4.  Caloric restriction and intermittent fasting: two potential diets for successful brain aging.

Authors:  Bronwen Martin; Mark P Mattson; Stuart Maudsley
Journal:  Ageing Res Rev       Date:  2006-08-08       Impact factor: 10.895

5.  Reduced energy intake: the secret to a long and healthy life?

Authors:  Bronwen Martin; Erin Golden; Josephine M Egan; Mark P Mattson; Stuart Maudsley
Journal:  IBS J Sci       Date:  2007-09

6.  Spatial reversal learning is impaired by age in pet dogs.

Authors:  Paolo Mongillo; Joseph A Araujo; Elisa Pitteri; Paolo Carnier; Serena Adamelli; Lucia Regolin; Lieta Marinelli
Journal:  Age (Dordr)       Date:  2013-03-26

Review 7.  A canine model of human aging and Alzheimer's disease.

Authors:  Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2013-03-23

8.  Strategies for improving cognition with aging: insights from a longitudinal study of antioxidant and behavioral enrichment in canines.

Authors:  Lori-Ann Christie; Wycliffe O Opii; Elizabeth Head
Journal:  Age (Dordr)       Date:  2008-06-22

9.  Assessment of nutritional interventions for modification of age-associated cognitive decline using a canine model of human aging.

Authors:  Joseph A Araujo; Christa M Studzinski; Elizabeth Head; Carl W Cotman; Norton W Milgram
Journal:  Age (Dordr)       Date:  2005-05-02

10.  Natural non-trasgenic animal models for research in Alzheimer's disease.

Authors:  Manuel Sarasa; Pedro Pesini
Journal:  Curr Alzheimer Res       Date:  2009-04       Impact factor: 3.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.